Vercruysse J Ph, De Foer B, Somers T h, Casselman J, Offeciers E
University Department of ENT, A.Z. Sint-Augustinus Hospital, Antwerp, Belgium.
B-ENT. 2009;5(4):233-40.
To report on the value and limitations of new MRI techniques in pre- and post-operative MRI of cholesteatoma. The current value of magnetic resonance imaging (MRI) in diagnosing congenital, acquired, and post-operative recurrent or residual cholesteatoma is described.
High resolution computed tomography (HRCT) is still considered the imaging modality of choice for detecting acquired or congenital middle ear cholesteatoma. However, MRI may provide additional information on the delineation and extension of cholesteatoma and on potential complications. Detecting post-operative residual or recurrent cholesteatoma with HRCT was shown to be inaccurate due to the technique's low sensitivity and specificity.
Recently, improvements in MRI techniques have led to a more accurate diagnoses of cholesteatoma using delayed contrast enhanced T1-weighted imaging and diffusion-weighted imaging.
报告新的MRI技术在胆脂瘤术前和术后MRI中的价值及局限性。描述磁共振成像(MRI)在诊断先天性、后天性以及术后复发性或残留性胆脂瘤方面的当前价值。
高分辨率计算机断层扫描(HRCT)仍被认为是检测后天性或先天性中耳胆脂瘤的首选成像方式。然而,MRI可能会在胆脂瘤的轮廓和范围以及潜在并发症方面提供额外信息。由于HRCT技术的低敏感性和特异性,用其检测术后残留或复发性胆脂瘤被证明是不准确的。
最近,MRI技术的改进使得使用延迟对比增强T1加权成像和扩散加权成像能更准确地诊断胆脂瘤。